Bio-Gene Technology Stock

Bio-Gene Technology EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Bio-Gene Technology (BGT.AX) as of Sep 5, 2026 is -2.64 M AUD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -2.37 M AUD — a change of 11.42% (lower).

EBITDA

-2.64 MAUD

YoY

11.42%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Bio-Gene Technology is 2026 -2.64 M AUD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Bio-Gene Technology was 2025 -2.37 M AUD. It decreases by 11.42% lower compared to the previous year.

The Bio-Gene Technology EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
-2.49 M AUD
Jan 1, 2019
-2.01 M AUD
Jan 1, 2020
-1.97 M AUD
Jan 1, 2021
-2.34 M AUD
Jan 1, 2022
-2.88 M AUD
Jan 1, 2023
-3.05 M AUD
Jan 1, 2024
-2.37 M AUD
Jan 1, 2025
-2.64 M AUD
The Bio-Gene Technology EBITDA history
YEAREBITDAYoY
-2.64 MAUD+11.42%
-2.37 MAUD-22.27%
-3.05 MAUD+6.03%
-2.88 MAUD+22.87%
-2.34 MAUD+18.66%
-1.97 MAUD-1.82%
-2.01 MAUD-19.33%
-2.49 MAUD+145.44%
-1.02 MAUD+230.97%
-306,700.00AUD+81.91%
-168,600.00AUD—
Access this data via the Eulerpool API
Get Free API Key

Bio-Gene Technology Stock analysis

What does Bio-Gene Technology do? Bio-Gene Technology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio-Gene Technology stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Bio-Gene Technology is -2.64 M AUD in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Bio-Gene Technology changed from -2.37 M AUD to -2.64 M AUD, representing a 11.42% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Bio-Gene Technology since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Bio-Gene Technology historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Bio-Gene Technology

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Bio-Gene Technology